Compared side by side
Pinealon vs cortagen: how they differ
The short answer
Both are short peptides from the Russian bioregulator program designed from brain-cortex peptides: pinealon is three amino acids (Glu-Asp-Arg), and cortagen four (Ala-Glu-Asp-Pro), designed from the cortex drug Cortexin. In cell and rodent studies pinealon protects nerve cells, with small uncontrolled Russian reports of cognitive gains, and in rats cortagen sped the regrowth of an injured nerve; no human study of cortagen has been published. Both are run in short courses rather than continuously, commonly 10–20 days a few times a year.
Side by side
| Compared | Pinealon | Cortagen |
|---|---|---|
| Category | Longevity | Cognitive |
| Also known as | EDR peptide, Tripeptide-4, Glu-Asp-Arg | Ala-Glu-Asp-Pro, AEDP peptide, Cortagene |
| What it is | A short synthetic peptide from the Russian bioregulator program, designed from brain-tissue extracts (not pineal tissue, despite the name). | A four-amino-acid peptide from the Russian bioregulator program, designed from the brain-cortex drug Cortexin. |
| How it works | Short synthetic tripeptide (Glu-Asp-Arg) designed from brain-cortex peptide extracts; the name refers to its intended target. Neuroprotective in cell and rodent studies from the developer's group, with small uncontrolled Russian reports of cognitive gains. Claimed to support melatonin, though no study has tested it. | A tetrapeptide, Ala-Glu-Asp-Pro (AEDP), that Vladimir Khavinson's St. Petersburg group designed from the amino acids of Cortexin, their peptide drug made from brain cortex. In rats with a cut and stitched sciatic nerve, the regrowing fibers grew 27% faster and carried signals 40% faster; in rats with chronic poor blood flow to the brain, a separate St. Petersburg group found it sped the recovery of behavior and limited oxidative damage, as Cortexin did. In mouse hearts it changed the activity of about a hundred genes, and in blood cells from people aged 75 to 88, grown in the lab, it loosened tightly packed chromatin. No human study of Cortagen is indexed on PubMed. |
| Commonly reported | Vivid dreams and deeper sleep, and clearer thinking during the cycle. Typically used in short 10–20 day cycles a few times a year, often alongside Epitalon. | Little to feel during a course, and now and then a light headache; user reports are few. |
| Studied range | Commonly run: 1–5 mg. No controlled study has set a dose of Pinealon: this is the range people commonly run, not a reference. | No human study has tested a dose of Cortagen: the amounts people run are their own protocol, not a reference. |
| How often | Daily for 10–20 day cycles, 2–3 cycles per year | Daily |
| Half-life | Short | Unknown (never measured) |
| Route | SubQ injection, Nasal | SubQ injection |
| Typical run | 10–20 day cycles, 2–3 times a year, similar to Epitalon. Often stacked with Epitalon in the same cycle. | Run in short courses rather than continuously, like the other bioregulators: community courses run about 10–20 days, a few times a year. In the rat nerve study it was given for 10 days after the injury. No study in people has tested a course length. |
| Evidence | Emerging: primarily preclinical / limited human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Vivid dreams, drowsiness, injection site reaction | Injection-site discomfort, occasional headache |
- Category
- PinealonLongevity
- CortagenCognitive
- Also known as
- PinealonEDR peptide, Tripeptide-4, Glu-Asp-Arg
- CortagenAla-Glu-Asp-Pro, AEDP peptide, Cortagene
- What it is
- PinealonA short synthetic peptide from the Russian bioregulator program, designed from brain-tissue extracts (not pineal tissue, despite the name).
- CortagenA four-amino-acid peptide from the Russian bioregulator program, designed from the brain-cortex drug Cortexin.
- How it works
- PinealonShort synthetic tripeptide (Glu-Asp-Arg) designed from brain-cortex peptide extracts; the name refers to its intended target. Neuroprotective in cell and rodent studies from the developer's group, with small uncontrolled Russian reports of cognitive gains. Claimed to support melatonin, though no study has tested it.
- CortagenA tetrapeptide, Ala-Glu-Asp-Pro (AEDP), that Vladimir Khavinson's St. Petersburg group designed from the amino acids of Cortexin, their peptide drug made from brain cortex. In rats with a cut and stitched sciatic nerve, the regrowing fibers grew 27% faster and carried signals 40% faster; in rats with chronic poor blood flow to the brain, a separate St. Petersburg group found it sped the recovery of behavior and limited oxidative damage, as Cortexin did. In mouse hearts it changed the activity of about a hundred genes, and in blood cells from people aged 75 to 88, grown in the lab, it loosened tightly packed chromatin. No human study of Cortagen is indexed on PubMed.
- Commonly reported
- PinealonVivid dreams and deeper sleep, and clearer thinking during the cycle. Typically used in short 10–20 day cycles a few times a year, often alongside Epitalon.
- CortagenLittle to feel during a course, and now and then a light headache; user reports are few.
- Studied range
- PinealonCommonly run: 1–5 mg. No controlled study has set a dose of Pinealon: this is the range people commonly run, not a reference.
- CortagenNo human study has tested a dose of Cortagen: the amounts people run are their own protocol, not a reference.
- How often
- PinealonDaily for 10–20 day cycles, 2–3 cycles per year
- CortagenDaily
- Half-life
- PinealonShort
- CortagenUnknown (never measured)
- Route
- PinealonSubQ injection, Nasal
- CortagenSubQ injection
- Typical run
- Pinealon10–20 day cycles, 2–3 times a year, similar to Epitalon. Often stacked with Epitalon in the same cycle.
- CortagenRun in short courses rather than continuously, like the other bioregulators: community courses run about 10–20 days, a few times a year. In the rat nerve study it was given for 10 days after the injury. No study in people has tested a course length.
- Evidence
- PinealonEmerging: primarily preclinical / limited human data
- CortagenEmerging: primarily preclinical / limited human data
- Common side effects
- PinealonVivid dreams, drowsiness, injection site reaction
- CortagenInjection-site discomfort, occasional headache
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Pinealon
- Day 1–10 The short cycle is the whole protocol
- Day 10–20 Cognitive clarity + closing the cycle
- Day 20–90 Off-cycle consolidation
Cortagen
- Day 1–10 Early days of a course
- Day 10–30 Where the nerve result comes from
Together or one or the other
Pinealon and cortagen are a common stack: cortagen lists pinealon among its common stacks.
Community · Cortagen
The two brain peptides
Cortagen and Pinealon are the bioregulator program's two brain peptides, and people often run them together; Epitalon commonly joins them. No study has tested them together.
Questions people ask
How long do pinealon and cortagen last?
The half-life of pinealon is short. The half-life of cortagen is unknown (never measured).
How often are pinealon and cortagen taken?
Pinealon: daily for 10–20 day cycles, 2–3 cycles per year. Routes: SubQ injection, nasal. Cortagen: daily. Route: SubQ injection.
How are pinealon and cortagen dosed in research?
pinealon is commonly run at 1–5 mg. No controlled study has set a dose of Pinealon: this is the range people commonly run, not a reference. The library carries no reference dose for cortagen. No human study has tested a dose of Cortagen: the amounts people run are their own protocol, not a reference.
What are the common side effects of pinealon and cortagen?
For pinealon, the library lists: vivid dreams, drowsiness, injection site reaction. For cortagen: injection-site discomfort, occasional headache.
Are pinealon and cortagen taken together?
Pinealon and cortagen are a common stack: cortagen lists pinealon among its common stacks. Cortagen and Pinealon are the bioregulator program's two brain peptides, and people often run them together; Epitalon commonly joins them. No study has tested them together.